The potential impact of pharmacogenetic testing on medication adherence.

Published

Journal Article

Poor medication adherence is a well-known problem, particularly in patients with chronic conditions, and is associated with significant morbidity, mortality and health-care costs. Multi-faceted and personalized interventions have shown the greatest success. Pharmacogenetic (PGx) testing may serve as another tool to boost patients' confidence in the safety and efficacy of prescribed medications. Here, we consider the potential impact (positively or negatively) of PGx testing on medication-taking behavior.

Full Text

Duke Authors

Cited Authors

  • Haga, SB; LaPointe, NMA

Published Date

  • December 2013

Published In

Volume / Issue

  • 13 / 6

Start / End Page

  • 481 - 483

PubMed ID

  • 23999596

Pubmed Central ID

  • 23999596

Electronic International Standard Serial Number (EISSN)

  • 1473-1150

Digital Object Identifier (DOI)

  • 10.1038/tpj.2013.33

Language

  • eng

Conference Location

  • United States